Also from this source

You just read:

SillaJen Announces First Patient Enrolled in Renal Cell Carcinoma Trial with Pexa-Vec in Combination with Regeneron's Cemiplimab

News provided by

SillaJen, Inc.

Jun 20, 2018, 09:00 ET